Latest filing published 11 Aug 2009 for AKORN INC.
No signal scores available.
Jerry N. Ellis discloses dealings in 2 companies, chiefly First Horizon Pharmaceutical Corp and Akorn Inc. We count 15 filings; the first trade dates from 15 June 2006 and the latest from 7 August 2009.
The open-market record consists of 5 sales worth €292k, with no purchase. Other entries cover 5 share grants and 5 option exercises.
The record was last updated on 11 August 2009 with a share grant in Akorn Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations